StockGlow

Alto Neuroscience, Inc. (ANRO)

Alto Neuroscience, Inc.

$27.71-0.03%Healthcare
Compare ANRO with
StockGlow Score
96
Bullish
BearishBullish
1 year ago+808.5%

The outlook

Alto Neuroscience, Inc. currently reads as bullish based on strong buy — 1.2 avg of 10 analysts, above its 50- & 200-day averages, 96% of the way from its 52-week low to high, avg target +29% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Analyst consensusStrong Buy — 1.2 avg of 10 analysts
Price trendAbove its 50- & 200-day averages
52-week range96% of the way from its 52-week low to high
Price targetAvg target +29% vs current price

Analyst price target

~12-month · 10 analysts
$35.64average target+28.6% vs now
Now $27.71
Low $24.00High $50.00

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$972.5M
52-wk high
$28.85
52-wk low
$3.00
50-day avg
$23.88
200-day avg
$19.45
Trailing P/E
—

Similar stocks

KYTXKyverna Therapeutics, Inc.$7.28-2.87%AVBPArriVent BioPharma, Inc.$30.01-2.10%ARTVArtiva Biotherapeutics, Inc.$10.02-3.93%CGONCG Oncology, Inc.$71.46-2.15%RAPPRapport Therapeutics, Inc.$41.73-2.45%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy